HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.

Abstract
The Staphylococcus aureus virulence factor clumping factor A (ClfA) is a component of an investigational S. aureus prophylactic vaccine. ClfA enables S. aureus to bind to fibrinogen and platelets during the initial stages of invasive disease. Here we demonstrate that ectopic expression of ClfA is sufficient to render nonpathogenic Lactococcus lactis lethal in a murine model of systemic infection. In contrast, L. lactis expressing ClfAY338A, which cannot bind fibrinogen, did not cause death in the mice. Pathogenicity was also prevented by immunization with ClfA. This model was then used to define a preclinical correlate of protection by measuring functional antibody in a S. aureus fibrinogen binding inhibition assay (FBI) and correlating that titer with protective outcomes. Although many humans have pre-existing antibodies that bind to ClfA, only sera with a threshold functional titer in the FBI were protective in this preclinical model. This confirms that fibrinogen binding is critical for ClfA-mediated pathogenesis and demonstrates that functional antibodies against ClfA are sufficient to protect against ClfA-mediated pathogenesis in vivo, enabling the definition of a preclinical correlate of protection for ClfA-containing vaccines based on FBI titer.
AuthorsIngrid L Scully, Yekaterina Timofeyeva, David Keeney, Yury V Matsuka, Elena Severina, Lisa K McNeil, Jasdeep Nanra, George Hu, Paul A Liberator, Kathrin U Jansen, Annaliesa S Anderson
JournalVaccine (Vaccine) Vol. 33 Issue 41 Pg. 5452-5457 (Oct 05 2015) ISSN: 1873-2518 [Electronic] Netherlands
PMID26319743 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
Chemical References
  • Antibodies, Bacterial
  • ClfA protein, Staphylococcus aureus
  • Coagulase
  • Recombinant Proteins
  • Fibrinogen
Topics
  • Animals
  • Antibodies, Bacterial (blood, immunology)
  • Coagulase (genetics, immunology, metabolism)
  • Disease Models, Animal
  • Fibrinogen (metabolism)
  • Humans
  • Immunization
  • Lactococcus lactis (immunology, metabolism)
  • Mice
  • Protein Binding
  • Recombinant Proteins (administration & dosage, immunology)
  • Staphylococcal Infections (immunology, microbiology, prevention & control)
  • Staphylococcus aureus (genetics, immunology, pathogenicity)
  • Virulence (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: